8-K
filed May 1, 2026, 7:59 PM ET
ticker CNTX
CIK 0001842952
litigation
confidence high
sentiment positive
materiality 0.60
Context Therapeutics resolves stockholder class action; $850K mootness fee paid by third party
Context Therapeutics Inc.
- Delaware court invalidated classified board and for-cause removal provisions from charter.
- Third-party service provider agreed to pay $850,000 mootness fee; company did not pay.
- Fee paid May 1, 2026; action to close after annual meeting scheduled June 24, 2026.
- Stipulated order granted April 30, 2026; court retains jurisdiction only for mootness fee application.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001628280-26-029323
- form_type
- 8-K
- ticker
- CNTX
- cik
- 0001842952
- company_name
- Context Therapeutics Inc.
- filed_at
- 2026-05-01T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.103603+00:00
- generated_at
- 2026-05-15T00:21:56.438111+00:00
- sec_items
- ["8.01"]
- event_type
- litigation
- sentiment
- positive
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001628280-26-029323
- json_url
- https://secwatch.observer/filing/0001628280-26-029323.json
- markdown_url
- https://secwatch.observer/filing/0001628280-26-029323.md
- text_url
- https://secwatch.observer/filing/0001628280-26-029323.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1842952/000162828026029323/0001628280-26-029323-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1842952/000162828026029323/cntx-20260430.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SAM
Boston Beer Co. gets $191M final judgement in Ardagh suit; interest lowered $21M
BOSTON BEER CO INC
June 1, 2026, 4:10 PM ET
litigation
Items 8.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
EXPI
Court grants preliminary approval of eXp's opt-in settlement in buyer-broker commission class action
eXp World Holdings, Inc.
May 29, 2026, 5:00 PM ET
litigation
Items 8.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
BNC
CEA Industries files suit against 10X Capital to void asset management agreement as unconscionable
CEA Industries Inc.
May 29, 2026, 4:10 PM ET
litigation
Items 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
SPCE
Virgin Galactic derivative suit settlement preliminarily approved; $2.75M from insurers
Virgin Galactic Holdings, Inc
May 28, 2026, 5:10 PM ET
litigation
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
NUAI
New Era Energy & Digital settles NM lawsuit for $1M; denies liability
New ERA Energy & Digital, Inc.
May 28, 2026, 4:22 PM ET
litigation
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
RYES
Rise Gold subsidiary loses summary judgment in Clean Water Act suit; disputes ruling
Rise Gold Corp.
May 22, 2026, 5:26 PM ET
litigation
Items 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
CRDF
Cardiff Oncology sues Nerviano Medical Sciences over onvansertib license inventorship dispute
Cardiff Oncology, Inc.
May 19, 2026, 5:01 PM ET
litigation
Items 8.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
HNST
Honest Co. derivative suit settlement preliminarily approved; $1.195M fee, governance reforms
Honest Company, Inc.
May 11, 2026, 6:13 PM ET
litigation
Items 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.